Qube Research & Technologies (QRT)’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Buy |
94,880
+41,315
| +77% | +$1.22M | ﹤0.01% | 1476 |
|
|
2025
Q1 | $1.6M | Sell |
53,565
-164,248
| -75% | -$4.9M | ﹤0.01% | 1612 |
|
|
2024
Q4 | $6.24M | Buy |
217,813
+149,666
| +220% | +$4.29M | 0.01% | 1069 |
|
|
2024
Q3 | $2.63M | Buy |
68,147
+13,691
| +25% | +$529K | ﹤0.01% | 1333 |
|
|
2024
Q2 | $1.75M | Buy |
+54,456
| New | +$1.75M | ﹤0.01% | 1430 |
|
|
2024
Q1 | – | Sell |
-16,001
| Closed | -$493K | – | 3990 |
|
|
2023
Q4 | $493K | Sell |
16,001
-111,009
| -87% | -$3.42M | ﹤0.01% | 1966 |
|
|
2023
Q3 | $2.84M | Buy |
127,010
+111,394
| +713% | +$2.49M | 0.01% | 962 |
|
|
2023
Q2 | $336K | Sell |
15,616
-19,348
| -55% | -$416K | ﹤0.01% | 1556 |
|
|
2023
Q1 | $839K | Buy |
+34,964
| New | +$839K | ﹤0.01% | 1301 |
|
|
2022
Q2 | – | Sell |
-19,699
| Closed | -$401K | – | 2569 |
|
|
2022
Q1 | $401K | Sell |
19,699
-62,177
| -76% | -$1.27M | ﹤0.01% | 1620 |
|
|
2021
Q4 | $1.53M | Buy |
81,876
+55,581
| +211% | +$1.04M | 0.01% | 956 |
|
|
2021
Q3 | $519K | Buy |
26,295
+8,280
| +46% | +$163K | 0.01% | 1198 |
|
|
2021
Q2 | $426K | Sell |
18,015
-1,844
| -9% | -$43.6K | ﹤0.01% | 1356 |
|
|
2021
Q1 | $471K | Sell |
19,859
-5,096
| -20% | -$121K | 0.01% | 1214 |
|
|
2020
Q4 | $500K | Buy |
+24,955
| New | +$500K | 0.01% | 1107 |
|
|
2020
Q1 | – | Sell |
-19,708
| Closed | -$406K | – | 1203 |
|
|
2019
Q4 | $406K | Buy |
+19,708
| New | +$406K | 0.01% | 1059 |
|